Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis

Guocan Yu; Qingshan Cai; Xudong Xu; Yanqin Shen; Kan Xu

doi:10.1371/journal.pone.0247494

Loading metrics

Open Access

Peer-reviewed

Registered Report Protocols describe a study’s rationale and methods for which the planned work was peer-reviewed prior to data collection.

See all article types »

Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis

Guocan Yu ,

Contributed equally to this work with: Guocan Yu, Qingshan Cai

Roles Data curation, Formal analysis, Funding acquisition, Methodology, Resources, Software, Writing – original draft, Writing – review & editing

Affiliation Zhejiang Tuberculosis Diagnosis and Treatment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
⨯
Qingshan Cai ,

Contributed equally to this work with: Guocan Yu, Qingshan Cai

Roles Data curation, Formal analysis, Funding acquisition, Methodology, Resources, Software, Validation

Affiliation Zhejiang Tuberculosis Diagnosis and Treatment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
⨯
Xudong Xu,

Roles Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

Affiliation Zhejiang Tuberculosis Diagnosis and Treatment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
⨯
Yanqin Shen,

Roles Resources, Software, Supervision, Validation

Affiliation Zhejiang Tuberculosis Diagnosis and Treatment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
⨯
Kan Xu

Roles Conceptualization, Data curation, Methodology, Project administration, Software, Writing – review & editing

* E-mail: xukanmed@163.com

Affiliation Zhejiang Tuberculosis Diagnosis and Treatment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
⨯

Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis

Guocan Yu,
Qingshan Cai,
Xudong Xu,
Yanqin Shen,
Kan Xu

Published: March 11, 2021
https://doi.org/10.1371/journal.pone.0247494

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Small cell lung cancer
Is the Subject Area "Small cell lung cancer" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Systematic reviews
Is the Subject Area "Systematic reviews" applicable to this article?

Thanks for your feedback.
Database searching
Is the Subject Area "Database searching" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.